Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Quarterly results
Appointed COO
Appointed director
HUMANIGEN, INC (HGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/19/2023 8-K Quarterly results
04/06/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
02/24/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
12/22/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
11/14/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
09/29/2022 8-K Quarterly results
09/02/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/26/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/12/2022 8-K Quarterly results
07/26/2022 8-K Quarterly results
07/13/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/12/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "EXHIBIG 10.1"
04/12/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "L REGISTRATIONAL 53 US 2"
02/28/2022 8-K Quarterly results
01/05/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
12/02/2021 8-K Quarterly results
11/26/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/12/2021 8-K Quarterly results
Docs: "Humanigen Reports Third Quarter and Nine Months Ending September 30, 2021 Financial Results and Provides Corporate Update"
11/09/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
10/20/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors"
10/05/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/14/2021 8-K Quarterly results
09/10/2021 8-K Quarterly results
08/12/2021 8-K Quarterly results
Docs: "Humanigen Reports Second Quarter 2021 Financial Results"
08/04/2021 8-K Investor presentation
Docs: "Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients",
"Humanigen Presentation “LIVE-AIR Phase 3 Study Update: Highest Response Rates Observed in Black and African-American Patients” dated August 2021"
07/14/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Humanigen July 14, 2021 Investor Presentation"
06/21/2021 8-K Quarterly results
06/17/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy